SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

11 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-09-15 10:34 UTC

"The house" visits the House

By Mike DolanThe nervous start to the week for world markets has seen 10-year U.S. Treasury yields top 5% to hit their highest in 19 years, just as Treasury Secretary Scott Bessent prepares to address Congress and the Federal Reserve starts its critical two-day meeting today.The prospect of interes…

News 2026-09-08 22:19 UTC

InnovAge reports 175% rise in adjusted EBITDA for fiscal 2026

InnovAge said fiscal 2026 adjusted EBITDA rose about 175% from fiscal 2025, with one-time legal accruals weighing on net income. It also guided fiscal 2027 revenue of $1.05 billion to $1.085 billion and adjusted EBITDA of $105 million to $115 million.

News 2026-06-30 16:44 UTC

Sarepta Moves Closer To FDA Approval For Duchenne Muscular Dystrophy Drugs

The U.S. Food and Drug Administration (FDA) accepted on Tuesday Sarepta Therapeutics Inc.’s (NASDAQ: SRPT ) supplemental New Drug Applications seeking to convert the accelerated approvals of AMONDYS 45 (casimersen) and VYONDYS 53 (golodirsen) into traditional approvals for Duchenne muscular dystrophy (DMD). • Sarepta T